PAX8 (Paired box protein Pax-8) variants and mutations
PAX8 (also known as Paired box protein Pax-8) is a human protein-coding gene encoding a paired box protein Pax-8 protein. It controls developmental and adult gene programs in the thyroid, kidney, and Mullerian-derived tissues. Heterozygous pathogenic variants can cause congenital hypothyroidism through thyroid dysgenesis or impaired thyroid-specific transcription. This analysis covers 876 PAX8 variants and mutations. Of these, 76% have computational variant effect predictions. Disease context includes hypothyroidism, congenital, nongoitrous, 2, congenital hypothyroidism, and hypothyroidism. Example PAX8 variants include P2L, H3D, and H3Y.
Variant analysis overview
- Gene: PAX8
- Protein: Paired box protein Pax-8
- UniProt accession: Q06710
- Organism: Homo sapiens
- Variants analyzed: 876
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 644 unspecified-consequence records; 8 stop lost; 1 stop retained variant; 17 synonymous variants; 177 missense variants; 9 frameshift variants; 13 stop-gained variants; 3 splice-region variants; 1 in-frame deletions; 3 substitution
- Prediction scores: 667 variants have prediction scores (76% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: hypothyroidism, congenital, nongoitrous, 2, congenital hypothyroidism, hypothyroidism, neurodegenerative disease, testicular hydrocele, thyroid hypoplasia, thyroid ectopia, cervix erosion, testicular disorder, spermatocele, thyroid tumor, athyreosis.
Protein structure and variant hotspots
- Protein features: 1 post-translational modification sites.
- PTM context: 1 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable PAX8 variants
Examples include P2L, H3D, H3Y, N4S, S5Y, R7K, R7S, R7T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- P2L (p.Pro2Leu), rs886054794, ClinGen CA10610660, ClinVar RCV000395300, TOPMed rs886054794, REVEL 0.67, CADD 27.10, Uncertain significance, Hypothyroidism, congenital, nongoitrous, 2
- H3D (p.His3Asp), TOPMed rs1174472803, gnomAD rs1174472803, REVEL 0.54, CADD 24.50
- H3Y (p.His3Tyr), NCI-TCGA Cosmic COSV5451, cosmic curated COSV54511, Variant assessed as somatic; moderate impact.
- N4S (p.Asn4Ser), TOPMed rs1356475693, gnomAD rs1356475693, REVEL 0.39, CADD 22.50
- S5Y (p.Ser5Tyr), cosmic curated COSV10880
- R7K (p.Arg7Lys), TOPMed rs979804694, gnomAD rs979804694, REVEL 0.43, CADD 23.60
- R7S (p.Arg7Ser), ExAC rs749031195, gnomAD rs749031195
- R7T (p.Arg7Thr), rs979804694, TOPMed rs979804694, gnomAD rs979804694, REVEL 0.58, CADD 24.00, Variant assessed as somatic; moderate impact.
- S8P (p.Ser8Pro), TOPMed rs1183904128, gnomAD rs1183904128, REVEL 0.47, CADD 24.40
- S8Y (p.Ser8Tyr), ExAC rs773089766, gnomAD rs773089766, REVEL 0.51, CADD 32.00
- H10Q (p.His10Gln), TOPMed rs987005552, gnomAD rs987005552, REVEL 0.61, CADD 13.00
- H10R (p.His10Arg), TOPMed rs1387635818, gnomAD rs1387635818, REVEL 0.89, CADD 25.00
- G11E (p.Gly11Glu), gnomAD rs1175043359, REVEL 0.97, CADD 26.00
- G11R (p.Gly11Arg), rs767674493, ExAC rs767674493, gnomAD rs767674493, ClinGen CA348303743, REVEL 0.97, CADD 27.20, Uncertain significance, Inborn genetic diseases; not provided
- G12R (p.Gly12Arg), cosmic curated COSV10880
- L13P (p.Leu13Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L13R (p.Leu13Arg), Ensembl rs1691366611, REVEL 0.94, CADD 28.70
- N14D (p.Asn14Asp), cosmic curated COSV54508
- G18R (p.Gly18Arg), Ensembl rs916127075
- G18V (p.Gly18Val), cosmic curated COSV99639, REVEL 0.99, CADD 25.60
- A19D (p.Ala19Asp), 1000Genomes rs2104507947, REVEL 0.80, CADD 25.60
- A19T (p.Ala19Thr), NCI-TCGA TCGA novel, TOPMed rs1691365431, REVEL 0.56, CADD 23.60, Uncertain significance, not provided
- R24S (p.Arg24Ser), Ensembl rs1573477019
- P25A (p.Pro25Ala), cosmic curated COSV54512
- P25S (p.Pro25Ser), cosmic curated COSV54506
- P27L (p.Pro27Leu), cosmic curated COSV10809, NCI-TCGA Cosmic COSV9964, Ensembl rs1691364108, REVEL 0.95, CADD 24.70, Variant assessed as somatic; moderate impact.
- P27Q (p.Pro27Gln), NCI-TCGA Cosmic COSV9964, cosmic curated COSV99640, Variant assessed as somatic; moderate impact.
- E28D (p.Glu28Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E28Q (p.Glu28Gln), gnomAD rs1303492062, REVEL 0.69, CADD 23.90
- V29G (p.Val29Gly), Ensembl rs1573476956
- V29M (p.Val29Met), ExAC rs750442664, gnomAD rs750442664, REVEL 0.78, CADD 24.90
- V30I (p.Val30Ile), rs765091370, ExAC rs765091370, TOPMed rs765091370, gnomAD rs765091370, REVEL 0.47, CADD 18.90, Variant assessed as somatic; moderate impact.
- R31C (p.Arg31Cys), rs761612832, ClinGen CA1840348, NCI-TCGA Cosmic COSV5450, cosmic curated COSV54507, AlphaMissense 1.00, MetaLR 0.99, Pathogenic/Likely pathogenic, not provided; Hypothyroidism, congenital, nongoitrous, 2
- R31H (p.Arg31His), rs104893657, ClinGen CA123461, NCI-TCGA Cosmic COSV9963, cosmic curated COSV99639, AlphaMissense 1.00, MetaLR 1.00, Pathogenic, not provided
- Q32R (p.Gln32Arg), TOPMed rs1028607843, gnomAD rs1028607843, REVEL 0.68, CADD 25.30
- R33C (p.Arg33Cys), rs776315252, ClinGen CA1840347, ClinVar RCV001200130, ExAC rs776315252, REVEL 0.94, CADD 28.00, Uncertain significance, not provided
- R33H (p.Arg33His), rs368109291, cosmic curated COSV99639, ESP rs368109291, ExAC rs368109291, REVEL 0.94, CADD 26.80, Variant assessed as somatic; moderate impact.
- R33S (p.Arg33Ser), cosmic curated COSV99048, REVEL 0.95, CADD 25.70
- I34L (p.Ile34Leu), ExAC rs760446471, TOPMed rs760446471, gnomAD rs760446471, REVEL 0.90, CADD 26.30
- I34N (p.Ile34Asn), rs1691361089, ClinGen CA348303516, NCI-TCGA Cosmic COSV9964, cosmic curated COSV99640, AlphaMissense 1.00, MetaLR 0.99, Pathogenic, Congenital hypothyroidism
- I34V (p.Ile34Val), ExAC rs760446471, TOPMed rs760446471, gnomAD rs760446471, REVEL 0.86, CADD 24.90
- V35A (p.Val35Ala), ExAC rs775121343, gnomAD rs775121343, REVEL 0.97, CADD 26.90
- V35I (p.Val35Ile), rs868015719, NCI-TCGA Cosmic COSV9964, cosmic curated COSV99640, TOPMed rs868015719, REVEL 0.85, CADD 25.00, Variant assessed as somatic; moderate impact.
- D36E (p.Asp36Glu), gnomAD rs1156243827, REVEL 0.50, CADD 21.30
- D36G (p.Asp36Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D36H (p.Asp36His), cosmic curated COSV10503
- D36Y (p.Asp36Tyr), NCI-TCGA Cosmic COSV9964, cosmic curated COSV99640, Variant assessed as somatic; moderate impact.
- A38D (p.Ala38Asp), NCI-TCGA Cosmic COSV9963, cosmic curated COSV99639, Ensembl rs1691360136, REVEL 0.97, CADD 28.00, Variant assessed as somatic; moderate impact.
- A38A (p.Ala38Ala), gnomAD 2-113227141-G-T, CADD 6.30
- A38V (p.Ala38Val), gnomAD 2-113227142-G-A, CADD 11.30
- A38T (p.Ala38Thr), rs1689628671, gnomAD 2-113227143-C-T, CADD 7.30
- A38S (p.Ala38Ser), gnomAD 2-113227143-C-A, CADD 5.40
- H39Q (p.His39Gln), ExAC rs745371541, TOPMed rs745371541, gnomAD rs745371541, REVEL 0.53, CADD 23.70
- H39Y (p.His39Tyr), ExAC rs771771303, gnomAD rs771771303, REVEL 0.89, CADD 26.40
- Q40E (p.Gln40Glu), ExAC rs778281768, TOPMed rs778281768, gnomAD rs778281768, REVEL 0.64, CADD 25.40
- Q40H (p.Gln40His), cosmic curated COSV99639, REVEL 0.66, CADD 22.40
- Q40P (p.Gln40Pro), rs104893656, ClinGen CA123469, ClinVar RCV000014798, UniProt VAR 012770, AlphaMissense 1.00, MetaLR 0.98, Pathogenic, Hypothyroidism, congenital, nongoitrous, 2
- G41D (p.Gly41Asp), rs2104507757, ClinGen CA348303446, ClinVar RCV001574478, Ensembl rs2104507757, AlphaMissense 1.00, MetaLR 0.99, Uncertain significance, not provided
- G41S (p.Gly41Ser), Ensembl rs1344687614
- V42I (p.Val42Ile), TOPMed rs1463993517, gnomAD rs1463993517, REVEL 0.57, CADD 23.80
- C45* (p.Cys45Ter), NCI-TCGA Cosmic COSV5450, cosmic curated COSV54507, CADD 25.00, Variant assessed as somatic; high impact.
- D46N (p.Asp46Asn), rs781575903, ClinGen CA1840338, ClinVar RCV002293021, ExAC rs781575903, REVEL 0.91, CADD 27.10, Likely pathogenic, not provided
- S48F (p.Ser48Phe), rs121917719, ClinGen CA123471, ClinVar RCV000014799, Ensembl rs121917719, REVEL 0.98, CADD 28.00, Pathogenic, Hypothyroidism, congenital, nongoitrous, 2
- S48T (p.Ser48Thr), Ensembl rs1691358061
- R49C (p.Arg49Cys), rs755170424, NCI-TCGA Cosmic COSV5450, cosmic curated COSV54506, ExAC rs755170424, AlphaMissense 1.00, MetaLR 0.99, Variant assessed as somatic; moderate impact.
- R49H (p.Arg49His), rs370069552, NCI-TCGA Cosmic COSV9963, cosmic curated COSV99639, ESP rs370069552, REVEL 0.97, CADD 28.30, Uncertain significance, not provided
- Q50H (p.Gln50His), Ensembl rs1691357353
- L51F (p.Leu51Phe), cosmic curated COSV54509
- R52C (p.Arg52Cys), rs751837678, ExAC rs751837678, TOPMed rs751837678, gnomAD rs751837678, REVEL 0.94, CADD 31.00, Uncertain significance, Inborn genetic diseases
- R52H (p.Arg52His), ESP rs370551984, ExAC rs370551984, gnomAD rs370551984, REVEL 0.93, CADD 27.20
- R52M (p.Arg52Met), gnomAD 2-113227145-C-A, CADD 13.60
- R52G (p.Arg52Gly), gnomAD 2-113227146-T-C, CADD 8.86
- V53I (p.Val53Ile), rs1336411411, TOPMed rs1336411411, gnomAD rs1336411411, REVEL 0.77, CADD 25.00, Variant assessed as somatic; moderate impact.
- S54C (p.Ser54Cys), rs104893660, ClinGen CA348303328, ClinVar RCV000502399, Ensembl rs104893660, AlphaMissense 1.00, MetaLR 0.99, Likely pathogenic, Hypothyroidism, congenital, nongoitrous, 2
- S54G (p.Ser54Gly), rs104893660, ClinGen CA123467, ClinVar RCV000014797, Ensembl rs104893660, AlphaMissense 1.00, MetaLR 0.99, Pathogenic, Hypothyroidism, congenital, nongoitrous, 2
- H55Q (p.His55Gln), rs121908742, ClinGen CA233200, ClinVar RCV000144426, Ensembl rs121908742, AlphaMissense 1.00, MetaLR 0.98, not provided
- G56C (p.Gly56Cys), NCI-TCGA Cosmic COSV9963, cosmic curated COSV99639, Variant assessed as somatic; moderate impact.
- G56G (p.Gly56Gly), gnomAD 2-113227138-G-T, CADD 11.10
- G56D (p.Gly56Asp), gnomAD 2-113227139-C-T, CADD 7.12
- G56V (p.Gly56Val), gnomAD 2-113227139-C-A, CADD 6.51
- G56S (p.Gly56Ser), rs149585280, gnomAD 2-113227140-C-T, CADD 4.50
- C57Y (p.Cys57Tyr), rs104893659, ClinGen CA123465, ClinVar RCV000014796, UniProt VAR 012771, AlphaMissense 1.00, MetaLR 0.99, Pathogenic, Hypothyroidism, congenital, nongoitrous, 2
- V58I (p.Val58Ile), rs373578525, cosmic curated COSV10503, ESP rs373578525, ExAC rs373578525, REVEL 0.85, CADD 25.40, Variant assessed as somatic; moderate impact.
- S59N (p.Ser59Asn), gnomAD rs1691354186, REVEL 0.92, CADD 25.30
- S59R (p.Ser59Arg), rs138235658, gnomAD 2-113227126-G-T, CADD 0.95
- S59A (p.Ser59Ala), gnomAD 2-113227128-TC-T, CADD 1.00
- K60N (p.Lys60Asn), gnomAD 2-113227111-C-G, CADD 7.99
- K60K (p.Lys60Lys), gnomAD 2-113227111-C-T, CADD 7.98
- K60E (p.Lys60Glu), gnomAD 2-113227113-T-C, CADD 7.55
- K60R (p.Lys60Arg), rs1021613853, gnomAD 2-113227118-T-C, CADD 6.98
- K60* (p.Lys60Ter), gnomAD 2-113227119-T-A, CADD 5.61
- L62H (p.Leu62His), cosmic curated COSV54507
- L62R (p.Leu62Arg), rs104893658, ClinGen CA123463, ClinVar RCV000014795, UniProt VAR 012772, AlphaMissense 1.00, MetaLR 0.99, Pathogenic, Hypothyroidism, congenital, nongoitrous, 2
- G63G (p.Gly63Gly), gnomAD 2-113227129-C-A, CADD 3.71
- G63W (p.Gly63Trp), gnomAD 2-113227131-C-A, CADD 8.21
- R64K (p.Arg64Lys), cosmic curated COSV54507, ExAC rs764033396, gnomAD rs764033396
- R64S (p.Arg64Ser), rs560233979, NCI-TCGA Cosmic COSV5450, cosmic curated COSV54507, 1000Genomes rs560233979, AlphaMissense 1.00, MetaLR 0.99, Variant assessed as somatic; moderate impact.
- R64M (p.Arg64Met), gnomAD 2-113227115-C-A, CADD 3.83
- R64R (p.Arg64Arg), gnomAD 2-113227116-T-G, CADD 0.96
- R64G (p.Arg64Gly), rs768894041, gnomAD 2-113227116-T-C, CADD 2.71
- Y65F (p.Tyr65Phe), 1000Genomes rs200673821, ESP rs200673821, ExAC rs200673821, TOPMed rs200673821, REVEL 0.82, CADD 26.50
- Y66* (p.Tyr66Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Y66Y (p.Tyr66Tyr), rs1573413379, gnomAD 2-113227108-A-G, CADD 2.28
- Y66F (p.Tyr66Phe), gnomAD 2-113227109-T-A, CADD 3.43
- Y66H (p.Tyr66His), gnomAD 2-113227110-A-G, CADD 0.94
- E67K (p.Glu67Lys), rs1289294447, NCI-TCGA Cosmic COSV5450, cosmic curated COSV54506, gnomAD rs1289294447, REVEL 0.97, CADD 27.40, Variant assessed as somatic; moderate impact.
- E67D (p.Glu67Asp), gnomAD 2-113227147-C-A, CADD 8.09
- E67* (p.Glu67Ter), gnomAD 2-113227149-C-A, CADD 10.80
- T68I (p.Thr68Ile), rs1691155605, ClinGen CA348302831, ClinVar RCV001093620, Ensembl rs1691155605, AlphaMissense 1.00, MetaLR 0.99, Likely pathogenic, Hypothyroidism, congenital, nongoitrous, 2
- T68T (p.Thr68Thr), gnomAD 2-113227123-A-G, CADD 7.77
- T68N (p.Thr68Asn), gnomAD 2-113227124-G-T, CADD 2.17
- T68A (p.Thr68Ala), rs776767792, gnomAD 2-113227125-T-C, CADD 5.17
- G69D (p.Gly69Asp), NCI-TCGA Cosmic COSV9963, cosmic curated COSV99639, Variant assessed as somatic; moderate impact.
- G69S (p.Gly69Ser), rs2466930096, ClinGen CA348302828, ClinVar RCV003985221, Likely pathogenic, Hypothyroidism, congenital, nongoitrous, 2
- S70R (p.Ser70Arg), ESP rs369162756, TOPMed rs369162756, gnomAD rs369162756
- S70N (p.Ser70Asn), rs1394782858, gnomAD 2-113227103-C-T, CADD 2.05
- I71T (p.Ile71Thr), gnomAD rs1340682275, REVEL 0.97, CADD 26.90
- R72Q (p.Arg72Gln), rs769138605, ClinGen CA1840301, cosmic curated COSV54508, ClinVar RCV000986802, REVEL 0.73, CADD 23.80, Likely benign, Hypothyroidism, congenital, nongoitrous, 2; Inborn genetic diseases
- R72W (p.Arg72Trp), NCI-TCGA Cosmic COSV5450, cosmic curated COSV54507, TOPMed rs1344770988, REVEL 0.92, CADD 29.20, Variant assessed as somatic; moderate impact.
- G74E (p.Gly74Glu), cosmic curated COSV10638
- G74R (p.Gly74Arg), cosmic curated COSV10503
- I76M (p.Ile76Met), gnomAD rs943067906, REVEL 0.80, CADD 23.40
- G77R (p.Gly77Arg), NCI-TCGA Cosmic COSV5451, Variant assessed as somatic; moderate impact.
- G78S (p.Gly78Ser), NCI-TCGA Cosmic COSV9963, cosmic curated COSV99639, Uncertain significance, Hypothyroidism, congenital, nongoitrous, 2
- S79C (p.Ser79Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S79F (p.Ser79Phe), rs1691154033, ClinGen CA348302717, ClinVar RCV001170073, Ensembl rs1691154033, AlphaMissense 1.00, MetaLR 0.99, Likely pathogenic, Hypothyroidism, congenital, nongoitrous, 2
- K82N (p.Lys82Asn), NCI-TCGA Cosmic COSV5451, cosmic curated COSV54511, Variant assessed as somatic; moderate impact.
- A84S (p.Ala84Ser), TOPMed rs958517751
- A84A (p.Ala84Ala), rs1397368690, gnomAD 2-113227120-T-G, CADD 8.08
- A84V (p.Ala84Val), gnomAD 2-113227121-G-A, CADD 0.40
- A84T (p.Ala84Thr), gnomAD 2-113227122-C-T, CADD 3.04
- T85N (p.Thr85Asn), ExAC rs772367877, TOPMed rs772367877, gnomAD rs772367877, REVEL 0.82, CADD 24.90
- T85P (p.Thr85Pro), cosmic curated COSV54512
- P86R (p.Pro86Arg), rs746024925, ClinGen CA1840296, ClinVar RCV000501288, ExAC rs746024925, REVEL 0.81, CADD 27.10, Uncertain significance, not specified
- P86T (p.Pro86Thr), TOPMed rs1269341622, gnomAD rs1269341622, REVEL 0.73, CADD 25.90
- K87M (p.Lys87Met), Ensembl rs2104498416
- K87N (p.Lys87Asn), cosmic curated COSV10880
- K87R (p.Lys87Arg), Ensembl rs2104498416, REVEL 0.62, CADD 26.40
- V88G (p.Val88Gly), Ensembl rs1573469789
- V89A (p.Val89Ala), TOPMed rs1691151206
- E90Q (p.Glu90Gln), Ensembl rs1691150764
- E90V (p.Glu90Val), TOPMed rs770096915, gnomAD rs770096915, REVEL 0.65, CADD 24.70
- K91R (p.Lys91Arg), Ensembl rs1691150484, REVEL 0.81, CADD 26.50
- I92T (p.Ile92Thr), gnomAD rs1246188811, REVEL 0.96, CADD 26.90
- G93A (p.Gly93Ala), rs1085307828, ClinGen CA348302550, ClinVar RCV000490149, TOPMed rs1085307828, REVEL 0.47, CADD 16.60, Uncertain significance, not provided
- G93E (p.Gly93Glu), TOPMed rs1085307828, gnomAD rs1085307828, Uncertain significance
- D94N (p.Asp94Asn), rs1573469745, ClinGen CA348302540, cosmic curated COSV54509, ClinVar RCV001130015, REVEL 0.59, CADD 23.90, Uncertain significance, Hypothyroidism, congenital, nongoitrous, 2
- Y95C (p.Tyr95Cys), cosmic curated COSV99639
- K96N (p.Lys96Asn), cosmic curated COSV10584
- K96T (p.Lys96Thr), Ensembl rs2104498329
- R97C (p.Arg97Cys), cosmic curated COSV54508, ExAC rs749370203, gnomAD rs749370203, REVEL 0.75, CADD 25.60, Uncertain significance, Inborn genetic diseases
- R97H (p.Arg97His), rs777910954, ExAC rs777910954, TOPMed rs777910954, gnomAD rs777910954, REVEL 0.76, CADD 26.60, Variant assessed as somatic; moderate impact.
- Q98* (p.Gln98Ter), cosmic curated COSV10503
- Q98H (p.Gln98His), gnomAD rs1319069401, REVEL 0.61, CADD 24.10
- N99K (p.Asn99Lys), ExAC rs762019177, TOPMed rs762019177, gnomAD rs762019177, REVEL 0.73, CADD 24.40, Uncertain significance
- N99S (p.Asn99Ser), 1000Genomes rs576393159, REVEL 0.80, CADD 25.60
- T101I (p.Thr101Ile), ExAC rs752572959, TOPMed rs752572959, gnomAD rs752572959, REVEL 0.88, CADD 26.10
- M102I (p.Met102Ile), ExAC rs767169161, TOPMed rs767169161, gnomAD rs767169161, REVEL 0.64, CADD 23.50, Uncertain significance, Inborn genetic diseases
- M102T (p.Met102Thr), gnomAD rs1343942490, REVEL 0.95, CADD 25.90
- W105* (p.Trp105Ter), cosmic curated COSV54510
- W105R (p.Trp105Arg), cosmic curated COSV10503
- W105S (p.Trp105Ser), rs1460732015, gnomAD 2-113227106-C-G, CADD 5.76
- W105L (p.Trp105Leu), gnomAD 2-113227106-C-A, CADD 6.98
- E106D (p.Glu106Asp), NCI-TCGA Cosmic COSV5450, cosmic curated COSV54508, Variant assessed as somatic; moderate impact.
- E106K (p.Glu106Lys), cosmic curated COSV10455
- R108* (p.Arg108Ter), rs104893655, ClinGen CA123459, ClinVar RCV000014793, Ensembl rs104893655, Pathogenic
- R108L (p.Arg108Leu), NCI-TCGA Cosmic COSV9964, cosmic curated COSV99640, Variant assessed as somatic; moderate impact.
- R108Q (p.Arg108Gln), gnomAD rs1333860789, REVEL 0.96, CADD 27.70, Uncertain significance, Inborn genetic diseases
- D109H (p.Asp109His), rs2466929606, ClinGen CA348302338, ClinVar RCV003152268, Uncertain significance, not provided
- R110L (p.Arg110Leu), cosmic curated COSV10880
- R110Q (p.Arg110Gln), cosmic curated COSV54510, ESP rs376820853, TOPMed rs376820853, gnomAD rs376820853, REVEL 0.80, CADD 27.20
- R110W (p.Arg110Trp), Ensembl rs1691146618, REVEL 0.86, CADD 28.70
- A113D (p.Ala113Asp), cosmic curated COSV10455
- A113S (p.Ala113Ser), ExAC rs766051649, TOPMed rs766051649, gnomAD rs766051649, REVEL 0.52, CADD 20.50
- A113T (p.Ala113Thr), ExAC rs766051649, TOPMed rs766051649, gnomAD rs766051649, REVEL 0.64, CADD 22.00
- A113V (p.Ala113Val), TOPMed rs1402172401, gnomAD rs1402172401, REVEL 0.71, CADD 24.60
- E114D (p.Glu114Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E114G (p.Glu114Gly), TOPMed rs1691145687, gnomAD rs1691145687, REVEL 0.93, CADD 29.30
- G115D (p.Gly115Asp), ESP rs201332404, ExAC rs201332404, TOPMed rs201332404, gnomAD rs201332404, REVEL 0.86, CADD 25.30
- V116A (p.Val116Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
Public PAX8 analysis runs
- PAX8 analysis run — PAX8 (876 variants) — completed 2026-08-20